Replicel Life Sciences Inc V.RP

Shiseido

[Ingiboy]

Curious to know what Shiseido is planning to do now that they are not obligated to pay any royalties to Replicel when they move forward with their version of RCH-01 (hijacked from Replicel).

We can only assume their second Trial has been completed as it is now at least 3 years since it started. Were the results compelling enough to take the treatment to market ?  Then the questions is outside of Japan where (or can) they market it ?

Next question is Replicel trying to make a deal with Shiseido to sell them the marketing rights to the rest of the world or is Shiseido going to ignore Replicel and market the treatment wherever they want ?

Lastly, what is Replicel working on if they are not negotiating with Shiseido (above) :
Sell the company outright
Move forward with their own version of the hair treatment in Japan
Submit the Dermal Injector for FDA Approval
Sell the Dermal injector
Take Replicel private

I am sure there are many more options.

[ZeoGak]

FWIW, Shiseido (SSDOY) SP last 5 years:

[ZeoGak]

OOPS, screen shoot failed. Link:  https://www.cnbc.com/quotes/SSDOY?tab=news Scoll and click 5 year on graft

[bluemoons20]

Not  quite  sure what we are looking at.   Shiseido  has been suffering for many years  and recently  appointed a new person in charge to try to turn things around.  Given their current situation  , if  your point is they may be interested inaquiring  Replical  ,  MAYBE  ,  but  lokely at  rock bottom  prices

[Ingiboy]

There is no chance the two biggest shareholders Andrew & Jamie will sell their 27,400,000 shares at $.08 - $.09 when their share average I am sure is in the $.15 - $.20 range.